Ann Transl Med
studied fasting and post-OGTT (oral glucose tolerance test) ghrelin concentrations in liver failure patients before and after liver transplantation
Additionally, in a standardized meal test, MC4R variant carriers were reported to exhibit suppressed hunger, enhanced satiety, and a 28% reduction in energy intake during an ad libitum feeding test, with no significant differences compared to the control group
Routine monitoring for thyroid cancer is not recommended by guidelines, but any concerning symptoms should be taken seriously and promptly assessed by a healthcare provider
Data from randomized controlled trials suggest that withdrawing either glucagon-like peptide-1 (GLP-1) receptor agonists or dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonists leads to a substantial regain of lost weight
Perhaps most notably for many patients, GLP-1 receptor agonists act on appetite centers in the brain, promoting satiety and reducing food intake